Enterprise imaging software developer Intelerad Medical Systems has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to use its InteleConnect EV mobile image review technology for diagnostic purposes.
InteleConnect EV had been previously cleared for viewing images on mobile devices for clinical purposes only. The expanded approval could help radiologists unable to access workstations during the COVID-19 pandemic to continue to work and collaborate with other physicians, the company noted.
The new clearance came during an FDA recertification of Intelerad's IntelePACS software. InteleConnect EV currently works on iPad and iPhone devices, and the company plans to add support for more devices in the future.
